Podcasts about Solar

Here is the link if you are interested in the NEW Social Media Platform: www.haveempathyandlove.com If you want to be part of the seven-day consecutive healing: Multi-Layered Healing https://network-7512321.mn.co/share/04JcQ7k8GONXvHMw?utm_source=manual If you have any questions: compasshealingcenter@gmail.com To schedule Emotion and Body Code Sessions: www.compasshealing.as.me --- Support this podcast: https://anchor.fm/healingthehealer/support

In this episode, Tyler zooms out and talks about perspective. Master the 7 steps to booking appointments that actually stick: https://www.solarsetterpro.com/ssp-orderJoin our slack to get in contact with us ASAP:  https://www.solarsales.pro/slackGet your free E-book: https://www.crush6figures.com/6fig-guidef

We are celebrating Independence Day with tips on how you can declare energy independence and freedom from fossil fuels by tapping into the power of the sun! On this week's show, we bring you more highlights from the June 4th Kentucky Solar Energy Society (http://kyses.org) Annual Meeting, hosted on campus by UofL's Sustainability Council. This week we'll hear from Andy McDonald, Director of Apogee - Climate & Energy Transitions, a Program of Earth Tools (https://apogeeclimate.org/); and Patrick Ferrell with the Solar Over Louisville installer, Solar Energy Solutions (https://www.sesre.com/). Andy shares all the basics you need to know as you consider solar power for your home, business, church, farm, or any other setting; and Patrick offers great information on home battery systems for solar – when you should consider them and when you shouldn't. The Kentucky Solar Energy Society's mission is to promote the use of renewable energy, energy efficiency, and conservation in Kentucky through education, advocacy, networking, and demonstration of practical applications. As always, our feature is followed by your community action calendar for the week, so get your calendars out and get ready to take action for sustainability NOW! Sustainability Now! airs on Forward Radio, 106.5fm, WFMP-LP Louisville, every Monday at 6pm and repeats Tuesdays at 12am and 10am. Find us at http://forwardradio.org The music in this podcast is courtesy of the local band Appalatin and is used by permission. Explore their delightful music at http://appalatin.com

El Solar Impulse 2 circunnavegó la Tierra en 2016 sin utilizar una sola gota de combustible.  Fue hecho con más de 17.000 paneles solares, mostrando lo que podría ser el futuro de los vuelos. Para conocer sobre cómo CNN protege la privacidad de su audiencia, visite CNN.com/privacidad

Australia has everything it needs to produce electricity - coal, gas, sun, and wind. Yet we've wound up with energy shortages and huge price hikes. How did we get here - why is our energy system in such a mess? And what can we do to fix it?

Listen to a recap of the top stories of the day from Electrek. Quick Charge is available now on Apple Podcasts, Spotify, TuneIn and our RSS feed for Overcast and other podcast players. New episodes of Quick Charge are recorded Monday through Thursday and again on Saturday. Subscribe to our podcast in Apple Podcast or your favorite podcast player to guarantee new episodes are delivered as soon as they're available. Stories we discuss in this episode (with links): Tesla offers free Supercharging to encourage off-peak charging during travels for holidays Tesla files to expand Gigafactory Texas with giant new building The Boring Company's Las Vegas Loop with Tesla vehicles connects to its first resort Toyota just started its BEV program, but it wasted all its tax credits on hybrids Opinion: EVs will be supply constrained until ICE cars die out https://youtu.be/nzf_6p49Nk8 var postYoutubePlayer;function onYouTubeIframeAPIReady() { postYoutubePlayer = new YT.Player( "post-youtube-video" ); } Subscribe to the Electrek Daily Channel on Youtube so you never miss a day of news Follow Mikey: Twitter @Mikey_Electric Listen & Subscribe: Apple Podcasts Spotify TuneIn Share your thoughts! Drop us a line at tips@electrek.co. You can also rate us in Apple Podcasts or recommend us in Overcast to help more people discover the show!

Dream Realm Enterprises is proud to present the latest adventure from DRE's Fan Produced Doctor Who Series - "Murder on the Solar Express" - Episode 3! STORY SYNOPSIS: The Doctor pushes his luck with Captain Nate. Will he push too hard? Or will he start to get to the bottom of what is really going on aboard the Solar Express?This story was written by Jonithan Patrick Russell. And stars: Paul Arbisi, David Ault, Gareth Bowley, Lexi DeSollar, Elie Hirschman, Tanja Melojevic, Lisa Michaud, Jerry Kokich, Eleiece Krawiec, Jonithan Patrick Russell, Joe Stofko, Joe J Thomas, Ted Wenskus, and Sally Wiget!RATED U - For Universal Audiences!DISCLAIMER:  NO ATTEMPT HAS BEEN MADE TO SUPERSEDE OR INFRINGE ANY EXISTING COPYRIGHT IN RELATION TO DOCTOR WHO OR ITS CONCEPTS AND SOUNDS, WHICH REMAIN PROPERTY OF THE BRITISH BROADCASTING CORPORATION.WE ARE A NOT-FOR-PROFIT ORGANIZATION. WHAT WE DO, WE DO FOR OUR FANS. THANK YOU FOR YOUR CONTINUED SUPPORT.

This week Kyt is joined by Pattycakes for a discussion of some of the finer points of exploding enemies in PVP with the Solar 3.0 Hunter abilities, along with a quick deep-dive on some of the best submachine guns in Destiny 2 PVP right now. Join us! Hear more from https://www.youtube.com/c/PattycakesGaming (Pattycakes on his YouTube channel) and click the About tab there to find his Twitch and all the socials! In this episode we specifically reference two of his recent videos, linked here: https://www.youtube.com/watch?v=fElEwEAVhZw (Top 3 Solar Hunter Builds) https://www.youtube.com/watch?v=rEzitrlmqCY&t=1016s (SMG Tier List) BECOME A PATRON: https://www.patreon.com/massivebreakdownpodcast (https://www.patreon.com/massivebreakdownpodcast) PVE POD: https://pve-podcast-versus-enemies.captivate.fm/listen (https://pve-podcast-versus-enemies.captivate.fm/listen) STAR WARS POD: https://beneath-twin-suns.captivate.fm/listen (https://beneath-twin-suns.captivate.fm/listen) CHAT SERVER: https://discord.gg/TheyfeQ (https://discord.gg/TheyfeQ) HOME PAGE: https://destinymassivebreakdowns.com (https://destinymassivebreakdowns.com)

El actor y presentador falleció a sus 49 años, pese a que se desconoce las causas oficiales de su muerte, el también modelo batalló por años contra el cáncer en los ganglios, que afecta el sistema linfático. Lo vamos a recordar por su positiva frase: “Arriba corazones”.¡Las noticias del espectáculo más chidas en el Bonuscast del Podcast del Show de Raul Brindis! 

In this episode, Tyler talks with Kota about the adversity and leaps of faith that are required to obtain wealth. Master the 7 steps to booking appointments that actually stick: https://www.solarsetterpro.com/ssp-orderJoin our slack to get in contact with us ASAP:  https://www.solarsales.pro/slackGet your free E-book: https://www.crush6figures.com/6fig-guidef

Seit einiger Zeit erlebt die Solarbranche einen Aufschwung - die Energiekrise hat den Boom zusätzlich befeuert. Welche Rolle wird die Sonnenkraft künftig spielen, kann sie die Lücke in unserer Energieversorgung füllen und erreichen wir die ehrgeizigen Ziele bis 2030? In dieser Folge sprechen wir mit Jürgen Reinert, dem Chef von SMA Solar Technology. Das Kasseler Unternehmen war lange führend im Bereich von Wechselrichtern, einem zentralen Steuerungsgerät in Photovoltaikanlagen – bietet inzwischen aber Systemlösungen an. Gerade errichtet SMA am Standort im nordhessischen Niestetal eine neue Fabrik – um die hohe Nachfrage zu bedienen. Reinert hat die dunklen Jahre der Solarbranche miterlebt und erklärt, was diesen Boom besonders macht, ob wir die Ausbauziele bis 2030 schaffen und unabhängig von Russland werden – und worauf Hausbesitzer beim Bau einer Solaranlage jetzt achten sollten // Weitere Themen: Wie lange bleibt die Inflation so hoch? Das Börsenupdate mit ntv-Expertin Katja Dofel +++60 Tage lang kostenlos Capital+ lesen - Zugriff auf alle digitalen Artikel, Inhalte aus dem Heft und das ePaper. Unter Capital.de/plus-gratis +++Unsere allgemeinen Datenschutzrichtlinien finden Sie unter https://art19.com/privacy. Die Datenschutzrichtlinien für Kalifornien sind unter https://art19.com/privacy#do-not-sell-my-info abrufbar.

Tanner Huber was a Co-Founder of Enlite Homes a 300+ person solar sales org. Currently Tanner is creating summer sales at V3 Electric and an avid real estate investor with a 6 million dollar portfolio! Tanner takes us through the tactical side of building out sales organizations Key Points:Align your empireInvest youngBuilding great sales teams is a processYou can't build a machine to success if you're not successfulConnect with Tanner:Facebook -https://www.facebook.com/tanner.huber.9Instagram - https://www.instagram.com/t_hubes/

Selon les derniers chiffres de Santé Publique France (2017), 39% des adolescents de 17 ans ont déjà expérimenté le cannabis. Julien a 25 ans, il a commencé à fumer à 11 ans et il a arrêté il y a 10 mois. Il vient témoigner sur ce sujet qui inquiète tant les parents. Pour discuter du sujet du cannabis chez nos ados, Dr Olivier Phan, psychiatre, chef de service en addictologie à la Fondation santé des étudiants de France, spécialisé dans la prévention, la formation, la recherche et la prise en charge des jeunes présentant des conduites addictives. Il écrit « Jeux vidéo, alcool, cannabis : prévenir et accompagner son adolescent » aux éditions Solar. Et également un manga « Kuza » pour la prévention des addictions chez les jeunes.

Managing an electrical grid that utilizes significant amounts of intermittent generation sources – solar and wind power – brings with it some unique challenges.  There are abundant wind resources in this country and more and utilities are taking advantage of these resources.   But there are times when there is more wind, times when there is […]

Listen to a recap of the top stories of the day from Electrek. Quick Charge is available now on Apple Podcasts, Spotify, TuneIn and our RSS feed for Overcast and other podcast players. New episodes of Quick Charge are recorded Monday through Thursday and again on Saturday. Subscribe to our podcast in Apple Podcast or your favorite podcast player to guarantee new episodes are delivered as soon as they're available. Stories we discuss in this episode (with links): Tesla Model S Plaid breaks 200 mph top speed for the first time Tesla uses its electric semi truck to deliver Superchargers to Laguna Seca racetrack GM teases proving ground image of Chevy Silverado EV, street testing to follow Drako Dragon: A new 1.9-sec 0-60 mph electric hypercar in a luxury SUV format Aqua superPower turns on its first marine fast charger in US https://youtu.be/T88cEIObf9k var postYoutubePlayer;function onYouTubeIframeAPIReady() { postYoutubePlayer = new YT.Player( "post-youtube-video" ); } Subscribe to the Electrek Daily Channel on Youtube so you never miss a day of news Follow Mikey: Twitter @Mikey_Electric Listen & Subscribe: Apple Podcasts Spotify TuneIn Share your thoughts! Drop us a line at tips@electrek.co. You can also rate us in Apple Podcasts or recommend us in Overcast to help more people discover the show!

Heute mit diesen Themen: - Samsung kauft deutsche Firma und entlässt alle Mitarbeiter - EU-Gremien einigen sich auf Verbot anonymer Kryptozahlungen - Elektroflugzeug aus Bayern fliegt zum ersten Mal - Millionenschwerer Rechtsstreit um die Spezi-Limo - Neue Akkus lassen E-Autos länger fahren - Weltraumblasen sollen Klimawandel stoppen

FTX exchange acquires crypto lender BlockFi. Ripple releases XRP Ledger updated named clio. El Salvador buys the bitcoin dip and is launching BTC solar mining.Sponsor

Solar Installation starts today --- Support this podcast: https://anchor.fm/FreeYourMind/support

FGR, obtiene orden de aprehensión contra el empresario Rafael Zaga Tawil y su hijo Elias Zaga HanonoMurió a los 49 años de edad, el conductor argentino, Fernando del SolarJueces de Florida y Kentucky se movilizaron para impedir que dichos estados prohíban el aborto

In this week's podcast we discuss the latest rising trends in financing, and financing for solar projects in particular. With rising inflation and interest rates, solar finance companies are increasing their loan fees to artificially reduce interest rates. We discuss strategies to help work through these issues to help keep solar projects affordable and advantageous. About Jamie Duran & Solar Harmonics Brought to you by Solar Harmonics in Northern California, who invite their customers to “Own Their Energy” by purchasing a solar panel system for their home, business, or farm. You can check out the website for the top solar energy equipment installer, Solar Harmonics, here. In each episode we discuss questions facing people making the decision to go solar. The solutions to your questions are given to you – straight – by one of the leading experts in the solar industry, Jamie Duran, president of Solar Harmonics. Feel free to search our library for answers to questions that you're facing when considering solar. About Adam Duran & Magnified Media Solarcast is produced and co-hosted by Adam Duran, director of Magnified Media. With offices in downtown San Francisco & Walnut Creek, California, Magnified Media is an internet marketing agency focused on digital marketing, local and national SEO, website design and lead generation for companies of all sizes. Magnified Media helps company leaders master their marketing by: • getting their website seen at the top of Google rankings, and • getting them more online reviews, • creating media content that engages with each client's target audience. In his spare time, Adam enjoys volunteering on the board of several community-based non-profits and his own weekly podcast Local SEO in 10.

Somewhere in between decentralized rooftop solar and sprawling rural utility-scale solar farms is a middle path that could allow companies go 100-percent renewable in under a year. New solar startup Evergreen is about to unleash the "Goldilocks" of solar with a trio of projects in South Texas. And they expect to scale up quickly in this overlooked niche, says Evergreen CEO Cris Eugster. Local listeners may recognize that name as the former CPS Energy COO and one-time sustainability manager. "I feel like we have a once-in-a-generation opportunity to figure out this energy transition and to tackle climate change," he said.

Crítica el presidente AMLO a los integrantes de la Iglesia Católica en México2 muertos y 2 heridos dejó un ataque armado afuera de un local comercial en AcapulcoA los 49 años de edad falleció el actor y conductor de televisión Fernando del Solar

Its here new solar equipment? --- Support this podcast: https://anchor.fm/FreeYourMind/support

Ramon Candia, Chief Investment Officer of Cifi, joins hosts Sarah Devine and Rebecca Abou-Chedid on Earth, Wind and Solar for a conversation about infrastructure development finance in Latin America and the Caribbean. Cifi has been innovating in the middle market infrastructure sector for the last 20 years and is focused on renewable and sustainable energy projects. The discussion covers recent transactions, a loan portfolio securitization, the Sustainable Fund and local currency funds, as well as green bonds, ESG considerations and future opportunities in the region.

Fermentieren: Bringt das was?; Spurenstoffzentrum des Bundes mit Startschwierigkeiten; Urintests zum Selbermachen: Darum sind sie wenig sinnvoll; Schwitzende Solarzellen können mehr leisten; Warum nehmen Babys alles in den Mund?; Die Stubenfliege ist wirklich liebenswert. Echt jetzt!; Mondflug - Darum schickt Deutschland jetzt Puppen; Moderation: Sebastian Sonntag. Von WDR 5.

Today's guest is Titiaan Palazzi, COO and Co-Founder at Myst. Myst is a machine learning platform that leverages AI technology to improve demand and supply forecasting for an increasingly renewable power grid. Their platform helps companies accelerate the deployment of expert forecasting solutions that not only increase profitability but also reduce risk. We have a great discussion about the different energy use cases that more accurate predictive modeling can help, the customer types that use Myst today, and the transition of data science talent into the climate space.Enjoy the show!You can find me on Twitter @codysimms (me), @mcjpod (podcast) or @mcjcollective (company). You can reach us via email at info@mcjcollective.com, where we encourage you to share your feedback on episodes and suggestions for future topics or guests.Episode recorded June 28, 2022. 

A conversation that goes behind the scenes of SOLAR — with Jonathan Bangs (Pilot Jamal Davis) Listen to the full interview on our Apple Podcasts Subscription Channel: Inside the Mission SOLAR+ See omnystudio.com/listener for privacy information.

Hoy respondo las siguientes preguntas: - Beneficios de la luz solar y riesgos de la luz artificial. - Combinación de alimentos (trofología o dietas disociadas): proteína y carbohidrato, fruta sola... - Limpiezas de colon, enemas de café... ¿Tienen sentido? - ¿Es útil la creatina para perder grasa? - Entrenamiento concurrente: combinación de fuerza y cardio. Como siempre, puedes escuchar también el episodio en iVoox, Spotify  y Apple Podcast. ¿Quieres un desayuno sano y rápido? Echa un vistazo a la avena overnight de La Newyorkina: https://fitnessrevolucionario.com/on Artículos: Beneficios de la luz solar. Peligros de la luz artificial. Mi charla en TEDx. La Revolución de la Glucosa. Creatina.

Listen to a recap of the top stories of the day from Electrek. Quick Charge is available now on Apple Podcasts, Spotify, TuneIn and our RSS feed for Overcast and other podcast players. New episodes of Quick Charge are recorded Monday through Thursday and again on Saturday. Subscribe to our podcast in Apple Podcast or your favorite podcast player to guarantee new episodes are delivered as soon as they're available. Stories we discuss in this episode (with links): Tesla ramps up Gigafactory Texas to thousands of units per week, adds new Model Y version Tesla 4680 cell: Samsung is building a pilot production line to build the new battery Tesla lets go of hundreds of Autopilot data labelers as it closes San Mateo office A Swedish firm is about to build the world's largest single offshore wind farm https://youtu.be/Ava7hLML420 var postYoutubePlayer;function onYouTubeIframeAPIReady() { postYoutubePlayer = new YT.Player( "post-youtube-video" ); } Subscribe to the Electrek Daily Channel on Youtube so you never miss a day of news Follow Mikey: Twitter @Mikey_Electric Listen & Subscribe: Apple Podcasts Spotify TuneIn Share your thoughts! Drop us a line at tips@electrek.co. You can also rate us in Apple Podcasts or recommend us in Overcast to help more people discover the show!

In this episode, Tyler breaks down how much practice you should have in relation with action.Master the 7 steps to booking appointments that actually stick: https://www.solarsetterpro.com/ssp-orderJoin our slack to get in contact with us ASAP:  https://www.solarsales.pro/slackGet your free E-book: https://www.crush6figures.com/6fig-guidef

Give us about ten minutes a day, and we will give you all the local news, local sports, local weather, and local events you can handle.   SPONSORS: Many thanks to our sponsors... Solar Energy Services because solar should be in your future! The Kristi Neidhardt Team. If you are looking to buy or sell your home, give Kristi a call at 888-860-7369! And- Alpha Engineering Today... The Annapolis Fire Department has some fireworks safety tips and we have two great local fireworks displays! K&B True Value Hardware and Solar Energy Systems cut the ribbon on the new solar system powering the local store! Tickets for the 17th Annual Boatyard Beach Bash (September) are on sale now so go get them NOW.  Housekeeping--no DNB Friday or Monday. Back with her weekly Annapolis After Dark is BeeprBuzz. She'll keep you up to speed on all of the fantastic live music we have in the area! And as usual, George from DCMDVA Weather is here with your local weather forecast! Please download their APP so you can keep on top of the local weather scene! The Eye On Annapolis Daily News Brief is produced every Monday through Friday at 6:00 am and available wherever you get your podcasts and also on our social media platforms--All Annapolis and Eye On Annapolis (FB) and @eyeonannapolis (TW) NOTE: For hearing impaired subscribers, a full transcript is available on Eye On Annapolis  

Podcast summary: In a time when life seems impossible and incomplete without the internet, maintaining data security and privacy can be a luxury sometimes as it is pretty easy to steal personal data and breach privacy using the same internet. Access to uncensored internet for all also looks like a hard-to-believe concept. This is where technologies such as dVPN come to the rescue. In today's podcast, Tanjima Elham Khandaker talks to Aleksandr Litreev, Founder and CEO of SOLAR Labs, the world's leading developer of dVPN technology. Aleksandr shares his background, how he came to work on dVPN and Web3 technologies, how they work to support users with internet safety and privacy and human rights which are intertwined with these issues. Aleksandr's bio: Aleksandr Litreev is Founder and CEO of SOLAR Labs, the world's leading developer of dVPN technology. The SOLAR Labs mission is to promote free speech, truth, and human rights globally, by empowering all people to have uncensored, untraceable, blockchain-enabled access to the internet via its decentralized applications and consumer hardware products, built exclusively at this time for the Cosmos blockchain ecosystem. Tanjima's bio: Tanjima Elham Khandaker is an MA student of Journalism, studying at the University of Roehampton, and an intern at the Irish Tech News. She is from Dhaka, Bangladesh. Back in her country, Tanjima worked for six and a half years as a journalist, sub-editor and senior sub-editor with a TV channel, an online news portal and a daily newspaper. She plans on becoming a better-skilled newsperson by pursuing further studies in the UK. Tanjima is a tech-enthusiast and dreams of walking on the moon one day.

Solar systems in snow globes?!  Preposterous yes, but it's a thing.  It's Crystal Spheres this week on DM Quicktips!   Head on over to our sponsor DSCRYB using this link https://dscryb.com/DMD Use code DMD at checkout for a free 2-week trial of DSCRYB Tell us what you think about this episode and gaming in general. If you're interested in a certain topic let us know, and we'll do an episode on it! We love doing this show, your support helps us keep creating and producing great content for you! Join our Patreon today. Our Patreon Page. https://www.patreon.com/thedmd Our Home page https://www.thedungeonmastersdojo.com/ On Facebook: https://www.facebook.com/TheDungeonMastersDojo On Twitter: https://twitter.com/DungeonDojo Or by Email: TheDungeonMastersDojo@Gmail.com

Listen to a recap of the top stories of the day from Electrek. Quick Charge is available now on Apple Podcasts, Spotify, TuneIn and our RSS feed for Overcast and other podcast players. New episodes of Quick Charge are recorded Monday through Thursday and again on Saturday. Subscribe to our podcast in Apple Podcast or your favorite podcast player to guarantee new episodes are delivered as soon as they're available. Stories we discuss in this episode (with links): 15,000 Tesla vehicles are already in the hands of Uber drivers through Hertz deal VW CEO believes Tesla will be weakened by ramping up 3 Gigafactories simultaneously VW and Siemens invest $450 million in Electrify America to accelerate EV charging infrastructure Cadillac Lyriq first drive: A year early and dollar long at $60K See leaked photos of Hyundai's Ioniq 6 before June 29 reveal Here are the only 5 countries opposing Europe's 2035 electric car-only rule https://youtu.be/vXmScqLM9kk var postYoutubePlayer;function onYouTubeIframeAPIReady() { postYoutubePlayer = new YT.Player( "post-youtube-video" ); } Subscribe to the Electrek Daily Channel on Youtube so you never miss a day of news Follow Mikey: Twitter @Mikey_Electric Listen & Subscribe: Apple Podcasts Spotify TuneIn Share your thoughts! Drop us a line at tips@electrek.co. You can also rate us in Apple Podcasts or recommend us in Overcast to help more people discover the show!

This week on the podcast we talk about Jackie's recent op-ed “Blackouts Could Drive a Return to Home Solar” with our guests Gursh Bal and Kai Fahrion, who are the Co-CEO's of Zeno, a residential home solar solutions provider. Jackie's op-ed argues that, while reducing power bills has been the historical reason for installing rooftop solar, the biggest push in the future will come from the increasing risk of power outages due to extreme weather. Electric vehicles and new financing options are other factors that are reducing the barriers to adoption. Here are some of the questions Peter and Jackie asked Gursh and Kai:  What is the typical size, cost and payback on a home solar installation?  How can the Ford F-150 Lightning electric truck's bidirectional feature increase home energy security?   Could a Canadian home go off-grid with these solutions? What is the outlook for residential solar? What are the common concerns when people consider home solar?Other content referenced in this week's podcast:Zeno's documentary on Peter's home solar installationCheck out Zeno's website: www.livezeno.com  Please review the ARC Energy Institute disclaimer.

This week, Columbia Energy Exchange brings you an episode of another podcast called Catalyst.  It's a weekly show hosted by climate tech veteran Shayle Kann about the future of decarbonization. Each week, different experts, researchers, and executives come on to unpack the latest hurdles to decarbonization and advancing new climate tech solutions.  This episode is all about weighing the risks and rewards of solar geoengineering.  In it, Shayle speaks with a climate modeler named Dan Visioni who conducts research on solar geoengineering at Cornell University's Sibley School of Mechanical and Aerospace Engineering.  They explore key questions, including: What do we know about the potential effects on ozone, precipitation and ecosystems? What do we need to research, and what could we learn by testing? Which could scale faster: carbon dioxide removal or solar geoengineering?   Solar geoengineering could cost a tiny fraction of the amount required to scale up carbon dioxide removal. Does that mean it could buy us time to draw down emissions in a less expensive manner? Or would its relative affordability enable a rogue actor to deploy it without international collaboration? And who gets to make the final decision on whether the world should deploy solar geoengineering? Whose hand is on the thermostat, so to speak? Episodes of Catalyst drop every Thursday. The show is a co-production of Post Script Media and Canary Media.

Here is a meditation who are participating in the Relationship Codes and Love Partnership Upgrades SOLAR Room. This consists of 7 days of Multi-Layered Healing with Emanuel Zevallos CECP, CBCP, CGEF. If you still wanted to participate feel free to join for free to our social media platform and look for the new SOLAR room. www.haveempathyandlove.com OR You can go directly to the room here: https://network-7512321.mn.co/share/LGquDZ4oNYyADUB-?utm_source=manual --- Support this podcast: https://anchor.fm/healingthehealer/support

Solar powered umbrellas sold at Costco recalled because they cam burst into flames, Australian man gives a whole new meaning to term 'car jacking' as he stops attempted theft of his ride, New company called 'Sky Cruise' rolls out rendering of futuristic flying nuclear hotel that can carry 5000 guest and never have to land

Schedule an appointment with Lyndsay here: https://calendly.com/lyndsay-thetank/consultingThanks to our sponsor Pi Syndicate for this episode!DOWNLOAD THE CHEAT SHEET HERE!  TOP 10 MOST DOWNLOADED EPISODES OF ALL TIME

What does it look like to build a career of purpose that also engages your natural talents for educating and relationship building? This week's Tactical Tuesday will show you! In today's episode, we feature Miguel Gil Mast of Schneider Electric. If you want to connect with today's guest, check out the https://mysuncast.com/suncast-episodes/ (show notes) over on the blog. SunCast is presented by https://www.mysuncast.com/sungrow (Sungrow), the world's most bankable inverter brand. You can learn more about all the sponsors who help make this show free for you, here: https://www.mysuncast.com/sponsors (www.mysuncast.com/sponsors) Remember you can always find the resources and learn more about today's guest, recommendations, book links, and more than 480 other founder stories and startup advice athttps://www.mysuncast.com/ ( www.mysuncast.com). You can connect with me, Nico Johnson, on https://www.twitter.com/nicomeo (Twitter), https://www.linkedin.com/in/nickalus/ (LinkedIn) or email.

Recorded by Will Alexander for Poem-a-Day, a series produced by the Academy of American Poets. Published on June 28, 2022. www.poets.org

Listen to a recap of the top stories of the day from Electrek. Quick Charge is available now on Apple Podcasts, Spotify, TuneIn and our RSS feed for Overcast and other podcast players. New episodes of Quick Charge are recorded Monday through Thursday and again on Saturday. Subscribe to our podcast in Apple Podcast or your favorite podcast player to guarantee new episodes are delivered as soon as they're available. Stories we discuss in this episode (with links): Tesla pauses some Berlin-built Model Y deliveries over electric motor issue Tesla Megapacks are about to replace Hawaii's last remaining coal plant Rivian's first DC fast charging sites are launching this week GMC Hummer EV will get new ‘Extract Mode,' delivering 16 inches of ground clearance Ford issues safety compliance recall on F-150 Lightning, citing issue with tire pressure increasing risk of crash Stock version of the Lucid Air Grand Touring wins fastest production car at Goodwood 2022 Volkswagen reveals ID. AERO concept — its first all-electric sedan offering a 385-mile range Watch an electric ‘fan car' beat every car ever at Goodwood Hill Climb Subscribe to the Electrek Daily Channel on Youtube so you never miss a day of news Follow Mikey: Twitter @Mikey_Electric Listen & Subscribe: Apple Podcasts Spotify TuneIn Share your thoughts! Drop us a line at tips@electrek.co. You can also rate us in Apple Podcasts or recommend us in Overcast to help more people discover the show!

JP's Product Pick of the Week 6/28/22 USB/DC/Solar Lipo Charger bq24074 DEEP discount during the livestream here! https://www.adafruit.com/product/4755 Visit the Adafruit shop online - http://www.adafruit.com ----------------------------------------- LIVE CHAT IS HERE! http://adafru.it/discord Adafruit on Instagram: https://www.instagram.com/adafruit Subscribe to Adafruit on YouTube: http://adafru.it/subscribe New tutorials on the Adafruit Learning System: http://learn.adafruit.com/ -----------------------------------------

An interview with Dr. Lynn Henry from the University of Michigan in Ann Arbor, MI, lead author on "Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update." Dr. Henry reviews new biomarkers for the purposes of making treatment decisions for triple-negative breast cancer, and hormone receptor-positive, HER2-negative breast cancer, as well as tumor agnostic tumor biomarkers. Specific biomarkers addressed in this conversation include PIK3CA, ESR1, BRCA 1/2, PALB2, HRD, PD-L1, dMMR/MSI-H, TMB, NTRK, ctDNA, and CTCs. Read the full guideline at www.asco.org/breast-cancer-guidelines.   TRANSCRIPT Brittany Harvey: Hello and welcome to the ASCO Guidelines Podcast series, brought to you by the ASCO Podcast Network, a collection of nine programs, covering a range of educational and scientific content and offering enriching insight into the world of cancer care. You can find all the shows including this one at asco.org/podcasts. My name is Brittany Harvey and today I'm interviewing Dr. Lynn Henry from the University of Michigan in Ann Arbor, Michigan, lead author on 'Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update'. Thank you for being here, Dr. Henry. Dr. Lynn Henry: Thank you very much for inviting me to participate. Brittany Harvey: First, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO conflict of interest policy is followed for each guideline. The full conflict of interest information for this guideline panel is available online with the publication of the guideline in the Journal of Clinical Oncology. Dr. Henry, do you have any relevant disclosures that are related to this guideline topic? Dr. Lynn Henry: No, I do not. Brittany Harvey: Great! Thank you. Then let's talk about the scope of this guideline. So, what prompted this update to the guideline on the use of biomarkers to guide decisions on systemic therapy for patients with metastatic breast cancer, which was last updated in 2015? And what is the scope of this guideline update? Dr. Lynn Henry: Yes, so a lot has happened in the past six or seven years that influence how we treat metastatic breast cancer. And there are many new drugs that have been approved by the FDA during that time. When we reviewed the prior guideline and the new treatment landscape, we realized that while much of what was included in the old guideline was still relevant, there were quite a number of new biomarkers related to new drugs that needed to be included. The newly recommended biomarkers are primarily applicable to making decisions about treatment of estrogen receptor, progesterone receptor, and HER2-negative breast cancer, also called triple-negative breast cancer, as well as for treatment of hormone receptor-positive HER2-negative breast cancer. And finally, there are now some tumor biomarkers that can be tested for that are tumor agnostic, and these were included as well. Brittany Harvey: Great! So, then let's discuss the updated guideline recommendations based off these new biomarkers for our listeners. The guideline reviews testing for several different biomarkers. So, I would like to review each of the biomarkers that the panel assessed. Let's start with what is the role of PIK3CA mutation testing? Dr. Lynn Henry: Yeah! So, PIK3CA activating mutations are commonly found in tumors that are hormone receptor-positive and HER2-negative. Based on the results of the SOLAR-1 trial, patients whose tumors have an activating PIK3CA mutation had improved progression-free survival when treated with the PI3 kinase inhibitor alpelisib plus fulvestrant compared to fulvestrant alone. This improvement was not seen in patients whose cancers didn't have a mutation. So, therefore, this provided the evidence for the clinical utility of evaluating tumors for the somatic PIK3CA mutations. Testing of either a tumor specimen or plasma to look for PIK3CA mutations can be performed. However, it's important that if the plasma is tested, and no PIK3CA mutations are identified in the circulating tumor DNA, then our tumor specimen should really be tested if possible, because of the possibility of a false negative finding in the plasma. Also, since these mutations can be acquired over time, a more recent specimen should be tested if possible, as opposed to testing the primary tumor. Finally, in the SOLAR-1 trial, a patient's tumor had to have one of the 11 pre-specified PIK3CA mutations in exon 7, 9, or 20. And therefore, when mutations are identified using next-generation sequencing, it is important to confirm that the identified mutation is one of those 11 activating mutations and not a different one that may not convey benefit from treatment with a PI3 kinase inhibitor. Brittany Harvey: Great! I appreciate you're reviewing that recommendation, as well as the clinical utility of it and the evidence behind it. So, then following those recommendations, what is the role of testing for ESR1 mutations? Dr. Lynn Henry: At this time, there are insufficient data to support routine testing of metastatic hormone receptor-positive HER2-negative tumors for ESR1 mutations. However, the panel did note that there's a retrospective analysis of two different phases three trials that demonstrated that fulvestrant improved progression-free survival compared to the aromatase inhibitor exemestane in patients who had previously progressed on a non-steroidal AI and whose tumors had an ESR1 mutation. Importantly, there are ongoing clinical trials addressing this issue, including the PADA-1 trial, which is evaluating the effect of the switch of fulvestrant from aromatase inhibitor therapy, versus remaining on that therapy when ESR1 mutations are detected in the blood. However, although preliminary findings were presented at a recent large breast cancer meeting, and were suggestive of a possible progression-free survival benefit from switching therapy, data have not yet been published, and therefore they were not included in this guideline. Brittany Harvey: Great! So, we'll look forward to those updated data to potentially review that recommendation in the future. So, following those recommendations, what is the role of testing for germline BRCA 1 or 2 and PALB2 pathogenic mutations? Dr. Lynn Henry: So, the answer for germline BRCA1 and BRCA2 mutations is relatively straightforward. Patients with metastatic HER2-negative breast cancer can be either hormone receptor-positive or negative, and who are candidates for treatment with a PARP inhibitor should undergo testing for germline BRCA1 and BRCA2 pathogenic or likely pathogenic mutations to determine whether they should receive treatment with a PARP inhibitor. This recommendation is based on the results of two large randomized clinical trials comparing PARP inhibitor therapy to physician's choice chemotherapy, although notably, the chemotherapy options did not include taxanes, anthracyclines, or platinums. In contrast, there remains insufficient evidence to support a recommendation either for or against testing for germline PALB2 pathogenic variant for the purpose of determining eligibility for treatment with a PARP inhibitor. The panel did note, however, that there are small single-arm studies that show that there is high response rate to PARP inhibitors in patients with metastatic breast cancer and coding DNA repair defects, such as either germline PALB2 pathogenic variants or somatic BRCA1 or 2 mutations. It was also noted that it is likely that patients who harbored mutations in these genes will actually be identified through routine testing with panel testing for germline variants. Brittany Harvey: Okay, understood. So, then following those recommendations, what is the role of testing tumors for homologous recombination deficiency? Dr. Lynn Henry: So, although there are emerging data from other solid tumors to support the use of homologous recombination deficiency, or HRD testing to guide therapy, current data do not support the assessment of HRD in the management of metastatic breast cancer. Therefore, we did not recommend routine testing of tumors for HRD at this time. Brittany Harvey: It's important to note where we both have evidence and where we don't have evidence. So, then what is the role of testing for expression of PD-L1 in metastatic breast cancer? Dr. Lynn Henry: So, the panel recommends that patients who are candidates for treatment with immunotherapy, with either a PD1 or PD-L1 inhibitor, should undergo testing for expression of PD-L1 in the tumor and immune cells with an FDA-approved test. At present in the United States, pembrolizumab is the only approved immunotherapy for the treatment of metastatic breast cancer, and it is given in combination with chemotherapy. The FDA-approved test for this drug is the 22C3 assay which evaluates PD-L1 staining in the tumor and surrounding stroma to calculate a combined positive score or CPS, with positive considered to be a score of 10 or greater. Of note, in other countries, there are different anti PD1 and PD-L1 antibodies that are approved for treatment, and each has been approved with its own companion diagnostic. So, it is important to make sure that you're using the right biomarker test, depending on which drug you are planning to use. Brittany Harvey: Great! I appreciate you reviewing the test in addition to the role of the biomarker. So, then, following those recommendations, what is the role of testing for deficient mismatch repair microsatellite instability-high? Dr. Lynn Henry: Similar to PD-L1 testing, it is recommended that patients with metastatic breast cancer who are candidates for a treatment regimen that includes an immune checkpoint inhibitor should undergo testing for deficient mismatch repair or microsatellite instability-high to determine eligibility for treatment with one of the drugs that is currently FDA approved, either dostarlimab or pembrolizumab. In contrast to the PD-L1 data, however, there are no randomized studies that have been conducted specifically in patients with breast cancer addressing this question. The testing recommendation was therefore included in these guidelines because of the tumor agnostic FDA approval of these drugs. In terms of which biomarker methodology to use, it was noted that, while the original studies assessed the deficient mismatch repair and MSI high using immunochemistry, and PCR respectively. The FDA has subsequently approved the next-generation sequencing platform to use in selecting candidates for these treatments. And so, therefore, there are a number of different tests that can be used. Brittany Harvey: Thank you for reviewing those recommendations as well. So, then following, what is the role of testing for tumor mutational burden? Dr. Henry Lynn: So, tumor mutational burden describes the quantity of somatic mutations in the tumor. Similar to the biomarkers we were previously discussing, there are minimal data specifically in metastatic breast cancer to support the assessment of tumor mutational burden for making treatment decisions. However, the testing recommendation was again included in the guidelines because of the tumor agnostic FDA approval of the drug pembrolizumab in the setting of high TMB. And also there is one single arm phase two trial that looked at this specifically. Importantly, the panel noted that there are a variety of factors that influence assessment of TMB. These include sample type, pre-analytical factors so how the sample was handled, the size of the panel and mutations that are tested, depths of the sequencing, type of the mutations that are included on the panel, and cut point variables. So, in particular, assessment of TMB in cell-free DNA assays such as circulating tumor DNA is an area of evolving evidence. There are therefore very important caveats to be aware of when selecting a TMB assay and assessing the results, many of which are outlined in the guideline manuscript itself, and different assays can yield different results for the same tissue specimen. It is therefore very important to use the approved companion assay and the approved cut point when making decisions regarding a specific treatment. Brittany Harvey: Absolutely. I appreciate your reviewing those details. So, then what is the role of testing for neurotrophic tyrosine receptor kinase? Dr. Lynn Henry: So, I'm going to abbreviate that to NTRK. So, NTRK fusions are rare in metastatic breast cancer. One study said 0.39% of all breast cancers have NTRK fusions. So, as with the above biomarkers, the NTRK testing recommendation is based on the results of phase 1 and phase 2 studies that were identified by the panel evaluating the efficacy and safety of these inhibitors for the treatment of advanced solid tumors with NTRK gene fusions, noting that there are only minimal data available that are specific to metastatic breast cancer. Brittany Harvey: Understood. Some of these are very rare in metastatic breast cancer. So, then, following that recommendation, what is the role of using circulating tumor DNA? Dr. Lynn Henry: So, for circulating tumor DNA, although the ctDNA technology holds promise in metastatic disease, for its ability to potentially identify tumor-specific mutations that are shed into the blood and that may be targetable, to date, neither the measurement of changes in ctDNA as a marker of treatment responsiveness nor identification of specific mutations in the blood to direct therapy has actually been prospectively shown to improve patient outcomes compared to standard imaging-based detection of tumor progression. Therefore, at present, the guideline does not recommend routine assessment of ctDNA for monitoring response to therapy among patients with metastatic breast cancer, although many studies are underway evaluating this question. Brittany Harvey: Understood. Then the last biomarker that the panel assessed in this guideline update, what is the role of using circulating tumor cells? Dr. Lynn Henry: Similar to circulating tumor DNA, there are insufficient data to recommend routine use of circulating tumor cells to monitor response to therapy among patients with metastatic breast cancer. To date, studies that have examined the clinical utility of this marker to determine the optimal time for treatment change have not led to improvements in outcomes in metastatic breast cancer. Brittany Harvey: Great! Well, thank you for reviewing all of these recommendations. The panel certainly took on a lot of biomarkers and performed a critical review of all the evidence to make recommendations in this setting. So, in your view, Dr. Henry, what is the importance of this guideline update and what should clinicians know as they implement these updated recommendations? Dr. Lynn Henry: Yeah, that's an excellent question. So, this guideline addresses the key questions that we face, as we're making decisions about how best to treat patients with metastatic breast cancer. Importantly, the guideline highlights the current state of the science, with a focus on the available published data from randomized clinical trials. It also discusses the limitations of our current knowledge, as well as key considerations for different biomarkers. Of course, we recognize that there are new data emerging on a regular basis. And the panel therefore also highlighted where data are anticipated but not yet available, as well as key questions which we hope will be able to be addressed in the more distant future. Brittany Harvey: And then finally, how will these guideline recommendations affect patients with metastatic breast cancer? Dr. Lynn Henry: Yeah, so really, that is the bottom line, isn't it? So, ideally, this guideline will enable the dissemination of best practices in terms of biomarker selection and analysis to guide clinicians as they are making treatment decisions in conjunction with patients. Treatment of metastatic breast cancer has become more complex, with regimen selection affected by both inherited germline genetics and somatic changes in the cancer that can evolve over time. The assessment of relevant biomarkers should allow patients to receive the optimal therapies that are most likely to be effective based on the individual characteristics of their cancers. Brittany Harvey: Well, I want to thank you so much for reviewing this guideline with me today, and all of the recommendations and our gaps in evidence, for our listeners. Thank you for your work on this guideline update and thank you for your time today, Dr. Henry. Dr. Lynn Henry: Thank you so much! Brittany Harvey: And thank you to all of our listeners for tuning in to the ASCO Guidelines podcast series. To read the full guideline, go to www.asco.org/breast-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO guidelines app available on iTunes or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.  

EP101: SCOTUS Rulings: Roe & Gun Law, Ghislaine Maxwell Sentencing, Clinton Kill List Mark Middleton Suicide Twitter Hiring FBI Agents, COVID Vaccines Not Working, Solar Kill Shot, Brittney Griner Russian Trial, NATO Increases Forces Sports - https://www.courttv.com/news/us-basketball-star-griner-appears-in-russian-court/ NATO Increasing Forces- https://www.defenseone.com/policy/2022/06/nato-approve-biggest-overhaul-defense-cold-war-leader-says/368629/ Space Weather - https://www.wired.com/story/sun-storm-end-civilization/ Ghislaine Maxwell Sentencing and Bill Clinton Aide Bizarre Suicide Mark Middleton - https://lawandcrime.com/live-trials/ghislaine-maxwell/ghislaine-maxwell-should-receive-up-to-the-maximum-penalty-for-the-horrific-sexual-abuse-of-multiple-young-teenage-girls-feds-say/ Media - FedTwitter https://www.mintpressnews.com/twitter-hiring-alarming-number-spooks-secret-agents/281114/ COVID - https://dailysceptic.org/2022/06/22/covid-vaccines-more-likely-to-put-you-in-hospital-than-keep-you-out-bmj-editors-analysis-of-pfizer-and-moderna-trial-data-finds/ & The news for Covid vaccines gets worse and worse SCOTUS overturns NYS gun law - https://www.usnews.com/news/politics/articles/2022-06-23/supreme-court-strikes-new-york-gun-law-in-major-ruling?fbclid=IwAR2NBftymmRNV6x3yI6Egzzx3NJf8YhP3FrNY_jcfI-gHaILwVdj6sR_w0k&fs=e&s=cl & https://pjmedia.com/news-and-politics/victoria-taft/2022/06/23/the-key-ways-justice-thomas-vanquished-gun-grabbers-in-his-bruen-decision-n1607542 Politics - SCOTUS Overturns Roe - https://legalinsurrection.com/2022/06/supreme-court-overrules-roe-v-wade/ & https://www.based-politics.com/2022/06/24/no-obergefell-isnt-going-to-be-overturned-after-roe-v-wade/ ## About the Sports, Clicks & Politics Podcast SCAPP is a weekly podcast with a Livestream every Monday at 12pm eastern. Join hosts Shawn Hannon and Ben Hussong as they separate the latest news from the noise impacting New York State. The podcast has frequent guest interviews for additional perspectives in the worlds or sports, politics and beyond! Follow the show on social media Website: scappodcast.com Facebook: facebook.com/scappodcast Twitter: @SCAPPodcast Follow Shawn & Ben on social media Facebook: facebook.com/hannon44 Twitter: @hannon44 Facebook: facebook.com/ben.hussong.3 Twitter: @benhussong ## --- Support this podcast: https://anchor.fm/scapp/support

In this episode, Tyler dives into one of humanity's greatest problems... procrastination. Master the 7 steps to booking appointments that actually stick: https://www.solarsetterpro.com/ssp-orderJoin our slack to get in contact with us ASAP:  https://www.solarsales.pro/slackGet your free E-book: https://www.crush6figures.com/6fig-guidef

Guest – CEO Joel HollandJoel is a technology entrepreneur, and his wife is a veterinarian. They are avid RVers based out of Vail, Colorado. After hundreds of nights spent RVing through